«Faculty for People with Intellectual Disabilities Dementia and People with Intellectual Disabilities Guidance on the assessment, diagnosis, ...»
Landt, J., D’Abrera, J.C., Holland, A.J., Aigbirhio, F.I., Fryer, T.D., Canales, R., Hong, Y.T., Mendon, D.K., Baron, J.C. & Zaman, S.H. (2011). Using positron emission tomography and Carbon 11–Labeled Pittsburgh compound B to image brain fibrillar b-Amyloid in adults with Down syndrome: Safety, acceptability, and feasibility. Archives of Neurology, 68(7), 890–896.
Leadership Alliance for the Care of Dying People (2014). One chance to get it right: Improving people’s experience of care in the last few days and hours of life. London: LACDP.
Learning Disabilities Observatory, RCGP, Public Health England. (2013). Improving the health and wellbeing of people with learning disabilities: An evidence-based commissioning guide for clinical commissioning groups (CCGs). Retrieved 24 February 2015 from http://www.improvinghealthandlives.org.uk/publications.
Lott, I.T., Osann, K., Doran, E. & Nelson, L. (2002). Down syndrome and Alzheimer disease: response to donepezil. Archives of Neurology, 59, 1133–6.
Lott, I.T., Doran, E., Nguyen, V.Q., Tournay, A., Head, E. & Gillen, D.L. (2011). Down syndrome and dementia: a randomized, controlled trial of antioxidant supplementation. American Journal of Medical Genetics Part A, 155(8), 1939–1948.
Lyketsos, C.G., DelCampo, L., Steinberg, M., Miles, Q., Steele, C.D., Munro, C., Baker, A.S., Sheppard, J.E., Frangakis, C., Brandt, J. & Rabins, P.V. (2003). Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS. Archives of General Psychiatry, 60, 737–746.
Lyngaard, H. & Alexander, N. (2004). ‘Why are my friends changing?’ Explaining dementia to people with learning disabilities. British Journal of Learning Disabilities, 32, 30–34.
Major, B. & McBrien, J. (2011). The value of prospective screening for dementia in adults with Down’s syndrome. Clinical Psychology Forum, 224, 44–48.
Mann, D. (1988). The pathological association between Down syndrome and Alzheimer disease. Mechanisms of ageing and development, 43(2), 99–136.
Marshall, M. (1998). How it helps to see dementia as a disability. Journal of Dementia Care.
Matthews, D.R. (2006). The ‘OK’ health check. Preston: Fairfield Publications.
McBrien, J.A. (2003). Assessment and diagnosis of depression in adults with intellectual disabilities: a review. Journal of Intellectual Disability Research, 47, 1–13.
McBrien, J. (2009). Screening adults with Down’s syndrome for early signs of dementia.
Journal of Integrated Care, 17(3), 3–7 McBrien, J.A., Whitwham, S., Olverman, K. & Masters, S. (2005). Screening adults with Down’s Syndrome for early signs of Alzheimer’s disease. Tizard Learning Disability Review, 10, 23–32.
104 Dementia and People with Intellectual Disabilities McCarron, M., Gill, M., Lawlor, B. & Begley, C. (2002). A pilot study of the reliability and validity of the Caregiver Activity Survey – Intellectual Disability (CAS-ID). Journal of Intellectual Disability Research, 46, 605–13.
McCarron, M., McCallion, P., Reilly, E. & Mulryan, N. (2014). A prospective 14-year longitudinal follow-up of dementia in persons with Down syndrome. Journal of Intellectual Disability Research, 58(1), 61–70.
McConkey, R., Mulvany, F. & Barron, S. (2006). Adult persons with intellectual disabilities on the island of Ireland. Journal of Intellectual Disability Research, 50, 227–236.
McGrother, C.W., Bhaumik, S., Thorp, C.F., Watson, J.M. & Taub, N.A. (2002). Prevalence, morbidity and service need among South Asian and white adults with intellectual disability in Leicestershire, UK. Journal of Intellectual Disability Research, 46, 299–309.
Mencap (2014). Making a will. Accessed at https://www.mencap.org.uk/our-services/willsand-trusts/guide-wills-and-trusts Menendez, M. (2005). Down syndrome, Alzheimer’s disease and seizures. Brain and Development, 27(4). 246–252.
Mindham, J. & Espie, C.A. (2003). Glasgow Anxiety Scale for people with an intellectual disability (GAS–ID): development and psychometric properties of a new measure for use with people with mild intellectual disability. Journal of Intellectual Disability Research, 47(1), 22–30.
Ministry of Health (2004). National Dementia Plan. Netherlands.
Moran, J.A., Rafii, M.S., Keller, S.M., Singh, B.K. & Janicki, M.P. (2013). The national task group on intellectual disabilities and dementia practices consensus recommendations for the evaluation and management of dementia in adults with intellectual disabilities. Mayo Clin Proceedings, 88(8), 831–840.
Morgan, D.G. & Stewart, N.J. (1999). The physical environment of special care units:
Needs of residents with dementia from the perspective of staff and family. Qualitative Health Research, 9(1), 105–118.
Moss, S. (2002a). The PAS-ADD checklist. Brighton: Pavilion Publishing.
Moss, S. (2002b). The Mini-PAS-ADD interview. Brighton: Pavilion Publishing.
Moss, S. & Patel, P. (1995). Psychiatric symptoms associated with dementia in older people with learning disability. British Journal of Psychiatry, 163, 471–80.
National Audit Office (2007). Improving services and support for people with dementia. London:
National Institute of Health and Care Excellence (2006). Dementia: Supporting people with dementia and their carers in health and social care. Clinical guidelines, CG42. Retrieved from www.nice.org.uk/CG42.
National Institute of Health and Care Excellence (2009). Medicines adherence: Involving patients in decisions about prescribed medicines and supporting adherence. Clinical guidelines CG 76. Retrieved from www.nice.org.uk/guidance/cg76.
Guidance on their Assessment, Diagnosis, Interventions and Support 105 National Institute for Health and Clinical Excellence (2010). Dementia Quality Standard 1.
Accessed at http://www.nice.org.uk/guidance/qs1/chapter/list-of-statements National Institute for Health and Clinical Excellence (2012a). Quality Standard for End of Life Care. Quality Standard 13. Accessed at http://www.nice.org.uk/guidance/QS13 National Institute for Health and Clinical Excellence (2012b). Dementia: Supporting people with dementia and their carers in health and social care. Clinical guideline CG42. Accessed at http://www.nice.org.uk/guidance/CG42 National Institute for Health and Clinical Excellence (2013). QS30 Supporting People to Live well with dementia. Retrieved from https://www.nice.org.uk/guidance/qs30 NHS National End of Life Care Programme (2011). The route to success in end of life care – Achieving quality for people with intellectual disabilities. Retrieved from www.endoflifecareforadults.nhs.uk Nihira, K., Foster, R., Shellhaas, M. & Leyland, H.. (1974). AAMD Adaptive Behaviour Scale 1974 Revision. Washington, DC: American Association on Mental Deficiency.
Nolan, B., Mathews, R.M., Truesdell-Todd, G. & VanDorp, A. (2002). Evaluation of the effect of orientation cues on wayfinding in persons with dementia. Alzheimer’s Care Quarterly, 3, 46–49.
Nyth, A. L. & Gottfries, C G. (1990). The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders in Nordic multicentric study. British Journal of Psychiatry, 157, 894–901.
O’Caoimh, R., Clune, Y. & Molloy, D.W. (2013). Screening for Alzheimer’s disease in Downs syndrome. Journal of Alzheimers Disease and Parkinsonism, http://dx.doi.org/10.4172/2161-0460.s7-001 Oliver, C., Kalsy, S., McQuillan, S. & Hall, S. (2011). Behavioural excesses and deficits associated with dementia in adults who have Down syndrome. Journal of Applied Research in Intellectual Disabilities, 24(3), 208–216.
Pollock, B.G., Mulsant, B.H., Rosen J, Sweet, R.A., Mazumdar, S., Bharucha, A., Marin, R., Jacob, N.J., Huber, K.A., Kastango, K.B. & Chew, M.L. (2002). Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients. American Journal of Psychiatry. 159, 460–465.
Prasher, V.P. (1997). Dementia questionnaire for persons with mental retardation (DMR).
Modified criteria for adults with Down syndrome. Journal of Applied Research in Intellectual Disabilities, 10, 54–60.
Prasher, V.P., Farrer, M.J., Kessling, A.M., Fisher, E.M.C., West, R.J., Barber, P.C. & Butler, A.C. (1998). Molecular mapping of Alzheimer-type dementia in Down’s syndrome.
Annals of Neurology, 43, 380–383.
Prasher, V.P., Huxley, A. & Haque, M.S. (2002). A 24-week, double-blind, placebocontrolled trial of donepezil in patients with Down syndrome and Alzheimer’s disease – Pilot study. International Journal of Geriatric Psychiatry, 17, 270–8.
106 Dementia and People with Intellectual Disabilities Prasher, V.P., Adams, C. & Holder, R. (2003). Long-term safety and efficacy of donepezil in
the treatment of dementia in Alzheimer’s disease in adults with Down syndrome:
open-label study. International Journal of Geriatric Psychiatry, 8, 549–51.
Prasher, V.P., Holder, R. & Asim, F. (2004). The Adaptive Behaviour Dementia Questionnaire (ABDQ): Screening questionnaire for dementia in Alzheimer’s disease in adults with Down syndrome. Research in Developmental Disabilities, 25, 385–97.
Prasher, V.P., Fung, N. & Adams, C. (2005). Rivastigmine in the treatment of dementia in Alzheimer’s disease in adults with Down syndrome. International Journal of Geriatric Psychiatry, 20, 496–7.
Prasher, V.P., Sachdeva, N., Adams, C. & Haque, M.S. (2013). Rivastigmine transdermal patches in the treatment of dementia in Alzheimer’s disease in adults with Down syndrome – pilot study. International Journal of Geriatric Psychiatry, 28(2), 219–220.
Regnard, C., Reynolds, J., Watson, B., Matthews, D., Gibson, L. & Clarke, C. (2007).
Understanding distress in people with severe communication difficulties: developing and assessing the Disability Distress Assessment Tool (DisDAT). Journal of Intellectual Disability Research, 51, 277–292.
Roth, R.M., Isquith, P.K. & Gioia, G.A. (2000). Behaviour Rating Inventory of Executive Function - Adult version (BRIEF-A). Hogrefe.
Royal College of Psychiatrists, British Psychological Society & Royal College of Speech and Language Therapists (2007). Challenging behaviour: A unified approach. London: Royal College of Psychiatrists.
Sampson, E.L., Candy, B. & Jones, L. (2009). Enteral tube feeding for older people with advanced dementia. Cochrane Database of Systematic Reviews, 2. art. no.: CD007209.
Saxton, J., McGonigle, K.L., Swihart, A.A. & Boller, F. (1993). The severe impairment battery.
Scottish Government (2013). Scotland’s National Dementia Strategy 2013–2016. Retrieved from http://www.scotland.gov.uk/Resource/0042/00423472.pdf.
Sharp, S. (2007). Home from home. London: Alzheimer’s Society.
Sheard, D.M. (2008). Feelings matter most. Brighton: Dementia Care Matters.
Sheard, D.M. (2013). The feeling of ‘mattering’: the positioning of emotions in dementia care. Journal of Dementia Care, 21, 23–27.
Sheehan, R., Sinai, A., Bass, N., Blatchford, P., Bohnen, I., Bonell, S. & Strydom, A. (2014).
Dementia diagnostic criteria in Down syndrome. International Journal of Geriatric Psychiatry. doi: 10.1002/gps.4228.
Sparrow, S.S., Cicchetti, D.V. & Balla, D.A. (2007). Vineland-II: Vineland Adaptive Behavior Scales (2nd edn.). Livonia, MN: Pearson.
Struwe, F. (1929). Histopatholoische Untersuchungen uber Enstehung und Wesen der senilen plaques. Zeitschrift für die gesamte. Neurologie und Psychiatrie, 122, 291–307.
Strydom, A. (2014). Report of the ADSID research group. Personal communication.
Guidance on their Assessment, Diagnosis, Interventions and Support 107 Strydom, A., Livingston, G., King, M. & Hassiotis, A. (2007). Prevalence of dementia in intellectual ability using different diagnostic criteria. British Journal of Psychiatry, 191, 150–157.
Strydom, A., Lee, L.A., Jokinen, N., Shooshtari, S., Rayka, V., Tor, J., Tsiouris, J.A., Courtenay, K., Bass, N., Sinnema, M., Maaskant, M.A. (2009). Report on the state of science on dementia in people with intellectual disabilities. IASSID Special Interest Research Group on Ageing and Intellectual Disabilities. Retrieved 24 Febraury 2015 from https://www.iassidd.org/uploads/legacy/images/documents/Aging/state%20of%20 the%20science%20dementia%202009.pdf.
Strydom, A., Shooshtari, S., Lee, L., Raykar, V., Torr, J., Tsiouris, J. & Maaskant, M. (2010).
Dementia in older adults with intellectual disabilities– epidemiology, presentation, and diagnosis. Journal of Policy and Practice in Intellectual Disabilities, 7(2), 96–110.
Strydom, A., Chan, T., Fenton, C., Jamieson-Craig, R., Livingston, G. & Hassiotis, A. (2013).
Validity of criteria for dementia in older people with intellectual disability. American Journal of Geriatric Psychiatry, 21(3), 279–288.
Sultzer, D.L., Gray, K.F., Gunay, I., Wheatley, M.V. & Mahler, M.E. (2002). Does behavioral improvement with Haloperidol or Trazodone treatment depend on psychosis or mood symptoms in patients with dementia? Journal of American Geriatric Society, 49, 1294–1300.
Surrey County Council (2011). Surrey Learning Disabilities & Dementia Strategy.
Thomas, K. & Department of Health (2005). Gold standards framework. London:
Department of Health.
Thompson, D. & Wright, S. (2001). Misplaced and forgotten: People with learning disabilities in residential services for older people. London: Foundation for People with Learning Disabilities.
Tuffrey-Wijne, I. & Watchman, K. (2014). Sharing the diagnosis of dementia: Breaking bad news to people with an intellectual disability. In K. Watchman (Ed.) Intellectual disability and dementia: Research into practice, chapter 10. London: Jessica Kingsley Publishers Turk, V., Dodd, K. & Christmas, M. (2001). Down’s syndrome and dementia: Briefing for Commissioners. London: Foundation for People with Learning Disabilities.
Tyrrell, J., Cosgrave, M., McCarron, M., McPherson, J., Calvert, J., Kelly, A., McLaughlin, M., Gill, M. & Lawlor, B.A. (2001). Dementia in people with Down’s syndrome.
International Journal of Geriatric Psychiatry,16(12), 1168–1174.